Correlation of serum HNE-specific ICs (A) or MDA-specific ICs (B) with SLEDAI scores.

The correlation was established by calculating correlation coefficients between HNE- or MDA-specific ICs and SLEDAI scores.</p

Serum levels of SOD, CAT and CIC4 in controls and SLE patients.

<p>Serum levels of SOD, CAT and CIC4 in controls and SLE patients.</p

Correlation of serum HNE-specific ICs (A) or MDA-specific ICs (B) with serum CICs.

<p>The correlation was established by calculating correlation coefficients between HNE- or MDA-specific ICs and serum CICs.</p

Correlation of serum HNE-protein adducts (A) or MDA-protein adducts (B) with IL-17A.

<p>The correlation was established by calculating correlation coefficients between serum HNE- or MDA-protein adducts and IL-17A.</p

HNE-and MDA-protein adducts in the sera of SLE patients with SLEDAI < 6 (n = 28) and SLEDAI ≥ 6 (SLEDAI> = 6 in the figure; n = 32) vs. controls (n = 32).

<p>The results are means ± SD. * p < 0.05 vs. controls; # p < 0.05 vs. SLEDAI < 6 patients.</p

Frequencies of different ECG findings and their impact on mortality in the GENISOS cohort.

<p>Frequencies of different ECG findings and their impact on mortality in the GENISOS cohort.</p

Association of ECG findings with low ejection fraction and elevated right ventricular systolic pressure on echocardiogram.

<p>Association of ECG findings with low ejection fraction and elevated right ventricular systolic pressure on echocardiogram.</p

Characteristics of patients with and without ECG abnormalities in the GENISOS Study Population.

<p>Characteristics of patients with and without ECG abnormalities in the GENISOS Study Population.</p